Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Clinical Trials Using Verteporfin

Review the clinical trials studying verteporfin on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-5 of 5

Photoradiation with Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Patients with Unresectable, Locally Advance or Metastatic Pancreatic Cancer
Status: Active
Location: Mayo Clinic in Rochester, Rochester, Minnesota
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
Status: Active
Location: Memorial Sloan Kettering Cancer Center, New York, New York
Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System
Status: Active
Location: Memorial Sloan Kettering Cancer Center, New York, New York
Interstitial Photodynamic Therapy following Palliative Radiotherapy in Treating Patients with Inoperable Malignant Central Airway Obstruction
Status: Active
Location: Roswell Park Cancer Institute, Buffalo, New York
An Open Label, Phase II Trial of Continuous Low-Irradiance Photodynamic Therapy (CLIPT) Using Verteporfin (Visudyne®) for the Treatment of Cutaneous Metastases of Breast Cancer
Status: Active
Location: See ClinicalTrials.gov